Talisadi Churna
Talisadi Churna is a classical Ayurvedic churna, a fine herbal powder. Listed in the Ayurvedic Formulary of India (AFI) Part I. Charaka Chikitsa Sthana 8/145-148. Sharangdhara Samhita, Madhyama Khanda 6/130-133. Essentially an extension of Sitopaladi Churna with the addition of Talisa (Abies webbiana) as the primary differentiating herb.
| Also known as | Talisadi Churna, TalisadiChurna |
|---|---|
| Pharmacopoeia status | Listed in the Ayurvedic Formulary of India (AFI) Part I. Referenced in Sharangdhara Samhita official compendia. Recognized by AYUSH as a standard respiratory formulation. |
Names and identification
| Language | Name |
|---|---|
| English | Talisadi Churna |
Where is it described in the classical texts?
Charaka Chikitsa Sthana 8/145-148. Sharangdhara Samhita, Madhyama Khanda 6/130-133. Essentially an extension of Sitopaladi Churna with the addition of Talisa (Abies webbiana) as the primary differentiating herb.
How does it work?
- Bronchodilator action: Piperine and volatile oils from Talisa and Pippali relax bronchial smooth muscle, improving airflow.
- Anti-inflammatory cytokine suppression: Gingerol (from Shunthi) and piperine inhibit IL-6 and TNF-alpha, reducing respiratory tract inflammation.
- Mucolytic and expectorant activity: Reduces sputum viscosity and promotes expectoration, clearing respiratory passages.
- Bioavailability enhancement: Piperine enhances absorption of other active compounds (cinnamaldehyde, cardamom essential oils).
- Digestive stimulation: Trikatu components kindle digestive fire (Agni), addressing the Ayurvedic principle that respiratory conditions often stem from impaired digestion.
Which traditional uses are supported by research?
- Chronic bronchitis (validated by 12-week clinical trial with significant improvements in LCQ, SGRQ, and PEFR scores)
- Productive cough and sputum reduction (validated by pilot study showing reduced sputum viscosity in 2 weeks)
- Respiratory tract inflammation (validated by in vitro IL-6 and TNF-alpha inhibition studies)
- Digestive weakness associated with respiratory conditions (validated by carminative and digestive stimulant properties)
What do recent clinical trials show?
4 further claims previously listed here could not be traced to a published paper and have been removed. Classical formulations are researched largely in journals that PubMed does not index, so an absence here reflects the reach of the index rather than the state of the evidence.
Recent safety updates
- Likely safe and well-tolerated in most people within therapeutic dosage. Higher doses may cause burning sensation and gastritis due to hot potency of Trikatu ingredients.
- Contains approximately 70% sugar content (Sharkara); patients with diabetes or high blood sugar should consult physician before use.
- Some formulations may contain trace heavy metals (lead, mercury, arsenic); quality-tested products from reputable manufacturers recommended. Not recommended for prolonged unsupervised use.
What is it made of?
Key Active Markers
- Derived from constituent herbs (see individual herb profiles)
- Standardized on primary bioactive markers
Analytical Methods: HPLC fingerprinting, TLC (identity), LC-MS/MS (marker quantification)
Dosage forms and preparation
Dosage Forms: Churna (fine powder), Capsule, Tablet
Standard Dosage: 1-3g with honey
Bioavailability: Powder form provides faster disintegration than tablets; particle size reduction enhances surface area for absorption
Optimal Timing: Multiple times daily for respiratory conditions
Shelf Life: 2 years (as per ASU guidelines for churna)
Storage: Airtight container, cool dry place, protected from moisture
Marker Compounds: Piperine, Gingerol
Quality Parameters: Mesh size NLT 85#, moisture NMT 6%, total ash per pharmacopoeia, assay of marker compounds: Piperine, Gingerol
Vehicle (Anupana): Honey
Synergistic Combinations
- With Honey as vehicle for enhanced absorption
Composition
As given in the Ayurvedic Formulary of India, Part I, entry 7:13 (TALISADYA CURNA), which cites Sarngadharasamhita, Madhyamakhanda, Adhyaya 6; 130-131.. Names, parts and quantities are transcribed as printed and checked row by row against the book. Manufacturers' versions of a classical formulation can differ from the formulary.
| # | Ingredient | Part | Quantity |
|---|---|---|---|
| 1 | Talisa | leaf | 12 g. |
| 2 | Marica | fruit | 24 g. |
| 3 | Sunthi | rhizome | 36 g. |
| 4 | Pippali | fruit | 48 g. |
| 5 | Vamsa-rocana (vamsa) | S.C. | 60 g. |
| 6 | Ela (suksmaila) * | seed | 6 g. |
| 7 | Tvak | stem bark | 6 g. |
| 8 | Sarkara | 384 g. |
* The scanned text was damaged at this row and the name was read from the entry's own Sanskrit verse.
Consult a qualified vaidya before acting on anything here. Ayurvedic practice is prescribed to a person, not to a condition: the same dravya is given, withheld or substituted depending on your constitution, your agni, the season and what else you are already taking. A page cannot know any of that. Self-prescribing from a reference is how the wrong preparation, the wrong dose or the wrong anupana gets used.
Educational reference only. Nothing on this page is medical advice, a diagnosis, or a recommendation to take anything. Traditional uses and research findings are reported as published, not as claims about what any product does. If you take prescribed medication, raise any interaction with the prescriber rather than acting on a page. See our editorial standards.